Stocks to watch today : 11 June 2025

and Distillers has received board’s approval for the acquisition of 100% of the equity share capital of UTO Asia (UTO Asia), a company incorporated under the laws of Singapore. The total consideration of this acquisition is Euro 1,225,000 (excluding stamp duty and levies). The binding transaction documents have been executed, and the acquisition is concluded with immediate effect Hrudayalaya’s wholly owned overseas subsidiary -- Health City Cayman Islands (HCCI) has infused an amount of $10,00,000 in Cayman Integrated Healthcare (CIHL), a wholly-owned overseas subsidiary of HCCI and a step-down subsidiary of the company by way of subscription to its equity shares equivalent to $1 million, i.e., 1,00,000 ordinary shares in the capital of the company, each as fully paid, with the value of each ordinary shares being set at $10.00, which is comprised $0.01 of par value and $9.99 of share premium. The above-mentioned shares have been allotted by CIHL to HCCI on June 10, 2025. With this investment, the total investment of HCCI in CIHL stands at $8,050,000. OneSource Specialty Pharma has entered into a partnership focused on the commercial manufacturing of Xbrane’s biosimilar portfolio. As part of the agreement, Xbrane will tech transfer its select product(s) to OneSource’s state-ofthe-art integrated Drug Substance and Drug Product (DS/DP) facility in Bangalore, India. The collaboration aims to strengthen Xbrane’s global supply chain, while enabling OneSource to accelerate regulatory approvals, including from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), for its biologics drug substance facility. As part of the collaboration, OneSource has also participated in Xbrane’s latest funding round, reinforcing the long-term alignment between the two companies.